Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study

Although anti-tumor necrosis factor-α monoclonal antibody biological preparations (BP) agents are widely used as an established treatment tool for refractory ulcerative colitis (UC), whether leukocytapheresis/granulocytapheresis (L/G-CAP) has similar beneficial impact on the disease activity remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Masahiro, Hayashi, Koichi, Ito, Tomoyuki, Otani, Haruka, Mori, Yuya, Ito, Shinsuke, Endo, Keita, Matsuda, Hiroto, Yoshino, Kaede, Kitamura, Koichi, Kubota, Eiji, Motomura, Yasuaki, Suzuki, Yasuhiro, Fujitani, Shigeki, Suzuki, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118317/
https://www.ncbi.nlm.nih.gov/pubmed/37083800
http://dx.doi.org/10.1097/MD.0000000000033368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118317/
https://www.ncbi.nlm.nih.gov/pubmed/37083800
http://dx.doi.org/10.1097/MD.0000000000033368

Ejemplares similares